Related Experiment Video

Updated: May 25, 2026

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
08:32

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

The heat shock proteins as targets for radiosensitization and chemosensitization in cancer

David M Guttmann1, Constantinos Koumenis

  • 1Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.

Cancer Biology & Therapy
|January 13, 2012
PubMed

Insights

Heat shock proteins (HSPs) aid cancer cell survival and proliferation. Targeting HSPs, especially small HSPs, may enhance radiation and chemotherapy effectiveness by sensitizing cancer cells.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Heat shock proteins (HSPs) are crucial for cell survival under stress, acting as molecular chaperones.
  • Elevated HSP expression is common in malignancies, supporting cancer cell proliferation and survival.
  • Cancer cells leverage HSPs' pro-survival functions to enhance their proliferative capacity.

Purpose of the Study:

  • To review HSPs' roles in malignancy.
  • To explore strategies targeting HSPs, particularly small HSPs, as sensitizers for cancer therapy.
  • To discuss proposed mechanisms of HSP-mediated sensitization.

Main Methods:

  • Literature review of HSPs in cancer biology.
  • Analysis of studies investigating HSP inhibition in preclinical cancer models.
  • Examination of proposed mechanisms for HSP-targeted therapy.

Main Results:

  • HSPs are implicated in various cancers, promoting tumor growth and resistance to therapy.
  • Targeting HSPs, especially small HSPs, shows promise in sensitizing cancer cells to radiation and chemotherapy.
  • Inhibition of HSPs can disrupt cancer cell survival pathways, increasing treatment efficacy.

Conclusions:

  • HSPs are significant contributors to cancer cell survival and therapeutic resistance.
  • Targeting HSPs represents a viable strategy to enhance the efficacy of existing cancer treatments.
  • Further research into HSP-targeted therapies, particularly small HSPs, is warranted to develop potent sensitizers.

More Related Videos

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors07:57

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors

Published on: January 20, 2023

Intracellular Refolding Assay07:18

Intracellular Refolding Assay

Published on: January 24, 2012

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Other Stress Responses in Bacteria01:30

Other Stress Responses in Bacteria

Bacteria have global regulatory systems that control several types of stress mechanisms. These include Pho regulon and the heat shock response, which are essential systems for environmental adaptation, such as nutrient limitation and proteotoxic stress. The Pho regulon and the heat shock response exemplify bacterial resilience, enabling rapid adaptation to fluctuating environmental conditions.Pho RegulonBacteria require phosphorus for essential cellular processes, including nucleic acid...